QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
NYSE:MED

Medifast - MED Stock Forecast, Price & News

$109.05
-5.17 (-4.53%)
(As of 01/30/2023 03:49 PM ET)
Add
Compare
Today's Range
$108.99
$114.18
50-Day Range
$111.79
$130.31
52-Week Range
$96.00
$204.14
Volume
136,722 shs
Average Volume
133,191 shs
Market Capitalization
$1.19 billion
P/E Ratio
8.27
Dividend Yield
5.74%
Price Target
$128.00

Medifast MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
15.9% Upside
$128.00 Price Target
Short Interest
Bearish
5.50% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.06
Upright™ Environmental Score
News Sentiment
0.59mentions of Medifast in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$60,222 Bought Last Quarter
Proj. Earnings Growth
2.00%
From $13.00 to $13.26 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Consumer Staples Sector

48th out of 138 stocks

Miscellaneous Food Preparations & Kindred Products Industry

2nd out of 5 stocks


MED stock logo

About Medifast (NYSE:MED) Stock

Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Solar Industry at Start of Long Bull Run?
The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.
Medifast (MED) Banks on OPTAVIA Strength Amid Cost Woes
7 Ridiculously Cheap Stocks Yielding 5% in 2023
15 Biggest Diet/Weight Loss Companies in the World
Medifast Stock Shows Promise At Current Valuation
Solar Industry at Start of Long Bull Run?
The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.
Medifast Third Quarter 2022 Earnings: Beats Expectations
Medifast to raise prices amid profit, revenue decline
Is It Time To Consider Buying Medifast, Inc. (NYSE:MED)?
Medifast, Inc. (MED)
The Truth About the Optavia Diet, According to a Nutritionist
10 Best Weight Loss Stocks To Buy Now - Yahoo Finance
See More Headlines
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Company Calendar

Ex-Dividend for 11/8 Dividend
9/19/2022
Last Earnings
11/03/2022
Dividend Payable
11/08/2022
Ex-Dividend for 2/7 Dividend
12/19/2022
Today
1/30/2023
Dividend Payable
2/07/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous food preparations & kindred products
Sub-Industry
Personal Products
CUSIP
58470H10
Employees
984
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$128.00
High Stock Price Forecast
$150.00
Low Stock Price Forecast
$106.00
Forecasted Upside/Downside
+17.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$164.03 million
Pretax Margin
12.10%

Debt

Sales & Book Value

Annual Sales
$1.53 billion
Cash Flow
$14.05 per share
Book Value
$17.43 per share

Miscellaneous

Free Float
10,676,000
Market Cap
$1.19 billion
Optionable
Optionable
Beta
1.18

Key Executives

  • Daniel R. ChardDaniel R. Chard
    Executive Chairman & Chief Executive Officer
  • Anthony Tyree
    Chief Business Operations Officer
  • James P. Maloney
    Chief Financial Officer
  • Nicholas M. Johnson
    Chief Field Operations Officer
  • Lauren Walker
    Executive Vice President-Supply Chain Operations













MED Stock - Frequently Asked Questions

Should I buy or sell Medifast stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares.
View MED analyst ratings
or view top-rated stocks.

What is Medifast's stock price forecast for 2023?

2 brokers have issued 1 year price objectives for Medifast's stock. Their MED share price forecasts range from $106.00 to $150.00. On average, they expect the company's share price to reach $128.00 in the next twelve months. This suggests a possible upside of 15.3% from the stock's current price.
View analysts price targets for MED
or view top-rated stocks among Wall Street analysts.

How have MED shares performed in 2023?

Medifast's stock was trading at $115.35 at the start of the year. Since then, MED stock has decreased by 3.8% and is now trading at $111.00.
View the best growth stocks for 2023 here
.

Are investors shorting Medifast?

Medifast saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 589,500 shares, an increase of 17.8% from the December 31st total of 500,400 shares. Based on an average trading volume of 138,400 shares, the short-interest ratio is presently 4.3 days. Approximately 5.5% of the shares of the stock are short sold.
View Medifast's Short Interest
.

When is Medifast's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our MED earnings forecast
.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) issued its quarterly earnings results on Thursday, November, 3rd. The specialty retailer reported $3.32 EPS for the quarter, topping analysts' consensus estimates of $1.91 by $1.41. The specialty retailer earned $390.40 million during the quarter. Medifast had a trailing twelve-month return on equity of 89.82% and a net margin of 9.22%.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, December 8th. Shareholders of record on Tuesday, December 20th will be given a dividend of $1.64 per share on Tuesday, February 7th. This represents a $6.56 dividend on an annualized basis and a dividend yield of 5.91%. The ex-dividend date of this dividend is Monday, December 19th.
Read our dividend analysis for MED
.

Is Medifast a good dividend stock?

Medifast (NYSE:MED) pays an annual dividend of $6.56 per share and currently has a dividend yield of 5.74%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 49.73%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MED will have a dividend payout ratio of 49.47% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MED.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $11.61-$13.05 for the period, compared to the consensus earnings per share estimate of $12.28. The company issued revenue guidance of $1.51 billion-$1.59 billion, compared to the consensus revenue estimate of $1.60 billion.

What is Daniel Chard's approval rating as Medifast's CEO?

44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by a number of institutional and retail investors. Top institutional investors include Rice Hall James & Associates LLC (2.46%), Chickasaw Capital Management LLC (0.26%), Allspring Global Investments Holdings LLC (0.20%), New York State Teachers Retirement System (0.17%), Campbell Newman Asset Management Inc. (0.14%) and National Bank of Canada FI (0.08%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends
.

How do I buy shares of Medifast?

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $111.00.

How much money does Medifast make?

Medifast (NYSE:MED) has a market capitalization of $1.21 billion and generates $1.53 billion in revenue each year. The specialty retailer earns $164.03 million in net income (profit) each year or $13.19 on an earnings per share basis.

How many employees does Medifast have?

The company employs 984 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The official website for the company is www.medifast1.com. The specialty retailer can be reached via phone at (410) 581-8042, via email at ir@choosemedifast.com, or via fax at 410-581-8070.

This page (NYSE:MED) was last updated on 1/30/2023 by MarketBeat.com Staff